Catalepsy
Research News and Information

Sunday, November 22, 2009

Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.

15 Jul 2009 Systemic inhibition of complex I by rotenone in rats represents a model of Parkinson's disease (PD). The aim of this study was to elucidate whether neramexane (NMDA, nicotinic alpha9/alpha10 and 5-HT3 receptor antagonist), idazoxan ... Read more...

[Effect of sulpiride on immobility reflex and pinch-induced catalepsy in CBA/Lac male mice with various social status]

29 Jun 2009 This study was aimed to determine the effect of D2/D3 receptor antagonist sulpiride on the expression of immobility reflex ("pinch-test") and pinch-induced catalepsy ("bar-test") of CBA/Lac male mice depending on their social status ("aggressors" ... Read more...

Righting elicited by novel or familiar auditory or vestibular stimulation in the haloperidol-treated rat: rat posturography as a model to study anticipatory motor control.

22 Jun 2009 External cues, including familiar music, can release Parkinson's disease patients from catalepsy but the neural basis of the effect is not well understood. In the present study, posturography, the study of posture and its allied reflexes, was used ... Read more...

Latest indexed articles for 'Catalepsy'

These are the very latest articles for this heading:

• Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats. 15 Jul 2009
• [Effect of sulpiride on immobility reflex and pinch-induced catalepsy in CBA/Lac male mice with various social status] 29 Jun 2009
• Righting elicited by novel or familiar auditory or vestibular stimulation in the haloperidol-treated rat: rat posturography as a model to study anticipatory motor control. 22 Jun 2009
• Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism. 10 Jun 2009
• Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys. 19 May 2009
• Ampullosporin A, a peptaibol from Sepedonium ampullosporum HKI-0053 with neuroleptic-like activity. 16 May 2009
• Effect of alpha lipoic acid on the tardive dyskinesia and oxidative stress induced by haloperidol in rats. 13 May 2009
• Learning and extinction of a passive avoidance response in mice with high levels of predisposition to catalepsy. 10 May 2009
• Narcolepsy--master of disguise: evidence-based recommendations for management. 29 Apr 2009
• A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol. 26 Apr 2009
• Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice. 12 Apr 2009
• Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice. 5 Apr 2009
• Chronic administration of imipramine normalizes decreased sexual motivation and increased predisposition to catalepsy induced by propylthiouracil in rats. 31 Mar 2009
• High fat diet and food restriction differentially modify the behavioral effects of quinpirole and raclopride in rats. 23 Mar 2009
• Therapeutic potential of alpha2 adrenoceptor antagonism for antipsychotic-induced extrapyramidal motor disorders. 3 Mar 2009
• Induction of Fos proteins in regions of the nucleus accumbens and ventrolateral striatum correlates with catalepsy and stereotypic behaviours induced by morphine. 27 Feb 2009
• [Effects of chronic fluoxetine treatment on catalepsy and immune response in mice genetically predisposed to freezing reaction: the role of 5-HT1A and 5-HT2A receptors and tph2 and SERT genes] 27 Feb 2009
• Dietary supplementations of amino acids: evidence for enhanced serotonergic functions following haloperidol withdrawal in rat medial prefrontal cortex. 27 Feb 2009
• Effect of gap junction inhibition on intracerebral hemorrhage-induced brain injury in mice. 27 Feb 2009
• Effects of 5-HT in globus pallidus on haloperidol-induced catalepsy in rats. 26 Feb 2009

See a longer list of these articles.

Technical information about 'Catalepsy'

Definition: A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed (waxy flexibility). Catalepsy may be associated with PSYCHOTIC DISORDERS (e.g., SCHIZOPHRENIA, CATATONIC), nervous system drug toxicity, and other conditions.

Descriptor UI: D002375

Alternative terms: Catalepsy; Catalepsies; Anochlesia; Anochlesias; Cerea Flexibilitas; Flexibilitas, Cerea; Flexibility, Waxy; Flexibilities, Waxy; Waxy Flexibilities; Waxy Flexibility;

Related Mesh Headings: Cataplexy; Catatonia; Freezing Reaction, Cataleptic;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C10.597.350.200; C23.888.592.350.200;

Technical Notes: do not confuse with CATAPLEXY